Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-042613
Filing Date
2011-07-28
Accepted
2011-07-28 16:08:03
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v227897_10q.htm 10-Q 794637
2 v227897_ex10-1.htm EX-10.1 13970
3 v227897_ex10-2.htm EX-10.2 20616
4 v227897_ex31-1.htm EX-31.1 13076
5 v227897_ex31-2.htm EX-31.2 12416
6 v227897_ex32-1.htm EX-32.1 7775
  Complete submission text file 0001144204-11-042613.txt   2525760

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20110630.xml EX-101.INS 302921
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20110630.xsd EX-101.SCH 14972
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20110630_cal.xml EX-101.CAL 26465
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20110630_def.xml EX-101.DEF 80033
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20110630_lab.xml EX-101.LAB 87142
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20110630_pre.xml EX-101.PRE 88281
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 11993807
SIC: 2834 Pharmaceutical Preparations